Risk Algorithm Using Biomarker May Double Screen-Detected Ovarian Cancers
the Cancer Therapy Advisor take:
Screening through the use of a risk of ovarian cancer algorithm (ROCA) doubled the number of screen-detected primary invasive epithelial ovarian or tubal cancers (iEOCs), according to a recent study published online ahead of print in the Journal of Clinical Oncology.
Researchers led by Usha Menon, MD, of the University College London looked at patient data of 640 women from the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Among these women, all of whom underwent surgery, the researchers found that 133 had primary iEOCs, with 22 interval iEOCs occurring within one year of screening.
ROCA alone was able to detect 87.1 percent of the iEOCs, compared with fixed CA-125 cutoffs which would have identified 41.5 percent of women with more than 35 U/mL, 48.4 percent of more than 30 U/mL, and 66.5 percent of more than 22 U/mL.
“In the context of cancer screening, reliance on predefined single-threshold rules may result in biomarkers of value being discarded,” the authors concluded.
Screening through the use of a risk of ovarian cancer algorithm doubled the number of screen-detected cancers.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- FDA Approves Ivosidenib for IDH1-Mutated Relapsed/Refractory Acute Myeloid Leukemia
- Clinical Stage at First Response May Predict Outcomes in Chronic Lymphocytic Leukemia
- Exercise and Cancer
- Increased Body Mass Index May Be Predictive of Recurrence, Progression in Bladder Cancer
- Aspirin, Non-Aspirin NSAID-Use May Improve Survival Outcomes in Ovarian Cancer